Answers to the Frequently Asked Questions Regarding Horse Feeding and Management Practices to Reduce the Risk of Atypical Myopathy.
- Journal Article
Summary
This research explores the connection between sycamore maple trees and atypical myopathy (AM), a toxification causing harm to horses, and offers guidance in identifying and mitigating risks associated with exposure to these trees. It focuses on managing horse feeding and environment to reduce the risk of intoxication.
Introduction
The study aims to address five key questions commonly asked about AM caused by sycamore maple trees. Led by an analysis of current literature and data collected from AM surveillance networks, the document provides recommendations on identifying potentially toxic trees, minimizing horse exposure to the toxins at both the grassland, and individual horse level, assessing the level of risk posed by pastures, and how risk periods can be effectively evaluated.
Identification of Toxic Trees
- The study provides a practical guide for distinguishing common maple trees from those that risk causing AM (FAQ 1).
Reducing Risk in Pastures
- Suggestions for mitigating the risk to horses cultivated at the pasture level include tactics such as avoiding wet pastures, preventing the spreading of manure on pastures that have sycamore maples nearby, and steering clear of having sycamore maple trees around pastures (FAQ 2).
Reducing Risk for Equids
- The study also proposes recommendations for lowering the risk at the level of individual horses. Proposed tactics include reducing pasture access time based on weather conditions, particularly during high-risk periods, offering supplementary food that does not contain toxins and water from distribution networks, and providing vitamins and a salt block (FAQ 3).
Risk Associated with Sycamore Pastures
- According to the research, all pastures that contain a sycamore tree in their vicinity present a risk, even if horses have previously been on these pastures without any poisoning incidents (FAQ 4).
Understanding the Risk Periods
- The study reveals that 94% of AM cases happen over two main 3-month periods, commencing in October and March, a pattern corresponding to the ingestion of seeds and seedlings respectively. This data significantly informs the appropriate timing and precautionary measures for those maintaining the welfare of horses on such pastures (FAQ 5).
Cite This Article
Publication
Researcher Affiliations
- Equine Pole, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liège, 4000 Liège 1 (Sart Tilman), Belgium.
- Department of Functional Sciences, Faculty of Veterinary Medicine, Pharmacology and Toxicology, Fundamental and Applied Research for Animals & Health (FARAH), University of Liège, 4000 Liège 1 (Sart Tilman), Belgium.
- Department of Functional Sciences, Faculty of Veterinary Medicine, Physiology and Sport Medicine, Fundamental and Applied Research for Animals & Health (FARAH), University of Liège, 4000 Liège 1 (Sart Tilman), Belgium.
- Department of Functional Sciences, Faculty of Veterinary Medicine, Pharmacology and Toxicology, Fundamental and Applied Research for Animals & Health (FARAH), University of Liège, 4000 Liège 1 (Sart Tilman), Belgium.
- Fourrages Mieux asbl, 6900 Marloie, Belgium.
- Equine Pole, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liège, 4000 Liège 1 (Sart Tilman), Belgium.
- Réseau d'Epidémio-Surveillance en Pathologie Équine (RESPE), 14280 Saint-Contest, France.
- Department of Functional Sciences, Faculty of Veterinary Medicine, Pharmacology and Toxicology, Fundamental and Applied Research for Animals & Health (FARAH), University of Liège, 4000 Liège 1 (Sart Tilman), Belgium.
Grant Funding
- Projet SAMA-D31-1381/S1 / Service Public de Wallonie
- 2018-2020-002 / Institut français du cheval et de l'équitation
- R.CRFA.2991 / Les Fonds Spéciaux pour la Recherche (FSR)
Conflict of Interest Statement
References
- Votion D.M., Van Galen G., Sweetman L., Boemer F., De Tullio P., Dopagne C., Lefère L., Mouithys-Mickalad A., Patarin F., Rouxhet S.. Identification of methylenecyclopropyl acetic acid in serum of European horses with atypical myopathy.. Equine Vet. J. 2014;46:146–149.
- Valberg S.J., Sponseller B.T., Hegeman A.D., Earing J., Bender J.B., Martinson K.L., Patterson S.E., Sweetman L.. Seasonal pasture myopathy/atypical myopathy in North America associated with ingestion of hypoglycin A within seeds of the box elder tree.. Equine Vet. J. 2013;45:419–426.
- Fowden L., Pratt H.M.. Cyclopropylamino acids of the genus Acer: Distribution and biosynthesis.. Phytochemistry 1973;12:1677–1681.
- Bochnia M., Sander J., Ziegler J., Terhardt M., Sander S., Janzen N., Cavalleri J.M., Zuraw A., Wensch-Dorendorf M., Zeyner A.. Detection of MCPG metabolites in horses with atypical myopathy.. PLoS ONE 2019;14:e0211698.
- Von Holt C., Chang J., von Holt M., Böhm H.. Metabolism and metabolic effects of hypoglycin.. Biochim. Biophys. Acta 1964;0:611–613.
- Melde K., Jackson S., Bartlett K., Stanley H., Sherratt H., Ghisla S.. Metabolic consequences of methylenecyclopropylglycine poisoning in rats.. Biochem. J. 1991;274:395–400.
- Westermann C.M., de Sain-van der Velden M.G.M., van der Kolk J.H., Berger R., Wijnberg I.D., Koeman J.P., Wanders R.J.A., Lenstra J.A., Testerink N., Vaandrager A.B.. Equine biochemical multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of rhabdomyolysis.. Mol. Genet. Metab. 2007;91:362–369.
- Palencia P., Rivero J.L.L.. Short Communications Atypical myopathy in two grazing horses in northern Spain.. Vet. Rec. 2007;161:346–348.
- Finno C.J., Valberg S.J., Wünschmann A., Murphy M.J.. Seasonal pasture myopathy in horses in the midwestern United States: 14 cases (1998–2005). J. Am. Vet. Med. Assoc. 2006;229:1134–1141.
- Votion D.M., Linden A., Saegerman C., Engels P., Erpicum M., Thiry E., Delguste C., Rouxhet S., Demoulin V., Navet R.. History and clinical features of atypical myopathy in horses in Belgium (2000–2005). J. Vet. Intern. Med. 2007;21:1380–1391.
- Van Galen G., Marcillaud Pitel C., Saegerman C., Patarin F., Amory H., Baily J.D., Cassart D., Gerber V., Hahn C., Harris P.. European outbreaks of atypical myopathy in grazing equids (2006–2009): Spatiotemporal distribution, history and clinical features.. Equine Vet. J. 2012;44:614–620.
- Gonzalez-Medina S., Ireland J.L., Piercy R.J., Newton J.R., Votion D.. Equine atypical myopathy in the UK: Epidemiological characteristics of cases reported from 2011 to 2015 and factors associated with survival.. Equine Vet. J. 2017;49:746–752.
- Brandt K., Brandtt K., Hinrrchs U., Schulze C., Landes E.. Atypische Myoglobinurie der Weidepferde.. Pferdeheilkunde 1997;13:27–34.
- Dunkel B., Ryan A., Haggett E., Knowles E.J.. Atypical myopathy in the South-East of England: Clinicopathological data and outcome in hospitalised horses.. Equine Vet. Educ. 2018:1–6.
- Van Galen G., Saegerman C., Marcillaud Pitel C., Patarin F., Amory H., Baily J.D., Cassart D., Gerber V., Hahn C., Harris P.. European outbreaks of atypical myopathy in grazing horses (2006–2009): Determination of indicators for risk and prognostic factors.. Equine Vet. J. 2012;44:621–625.
- Bunert C., Langer S., Votion D.M., Boemer F., Muller A., Ternes K., Liesegang A.. Atypical myopathy in Pere David’s deer (Elaphurus davidianus) associated with ingestion of hypoglycin A.. J. Anim. Sci. 2018;96:3537–3547.
- Votion D.M., Linden A., Delguste C., Amory H., Thiry E., Engels P., Van Galen G., Navet R., Sluse F., Serteyn D.. Atypical myopathy in grazing horses: A first exploratory data analysis.. Vet. J. 2009;180:77–87.
- Westermann C.M., van Leeuwen R., van Raamsdonk L.W.D., Mol H.G.J.. Hypoglycin A Concentrations in Maple Tree Species in the Netherlands and the Occurrence of Atypical Myopathy in Horses.. J. Vet. Intern. Med. 2016;30:880–884.
- Renaud B., François A.-C., Dopagne C., Rouxhet S., Gustin P., Votion D.. Identification of the Maple Tree Responsible for Atypical Myopathy.. [(accessed on 12 December 2019)]; Available online: http://hdl.handle.net/2268/242221.
- Van Galen G., Dopagne C., Rouxhet S., Pitel C., Votion D.. Etiologie de la myopathie atypique: Conditions de toxicité de l’agent causal—Étude préliminaire. 40ème Journée de la Recherche Equine Institut français du cheval et de l’équitation (IFCE); Paris, France: 2014. pp. 101–109.
- . Search Results—The Plant List.. [(accessed on 12 December 2019)]; Available online: http://www.theplantlist.org/tpl/search?q=Acer&_csv=on.
- Hulme P.E., Bacher S., Kenis M., Klotz S., Kühn I., Minchin D., Nentwig W., Olenin S., Panov V., Pergl J.. Grasping at the routes of biological invasions: A framework for integrating pathways into policy.. J. Appl. Ecol. 2008;45:403–441.
- Unger L., Nicholson A., Jewitt E.M., Gerber V., Hegeman A., Sweetman L., Valberg S.. Hypoglycin A Concentrations in Seeds of Acer Pseudoplatanus Trees Growing on Atypical Myopathy-Affected and Control Pastures.. J. Vet. Intern. Med. 2014;28:1289–1293.
- Baise E., Habyarimana J.A., Amory H., Boemer F., Douny C., Gustin P., Marcillaud-Pitel C., Patarin F., Weber M., Votion D.M.. Samaras and seedlings of Acer pseudoplatanus are potential sources of hypoglycin A intoxication in atypical myopathy without necessarily inducing clinical signs.. Equine Vet. J. 2016;48:414–417.
- Zuraw A., Dietert K., Kühnel S., Sander J., Klopfleisch R.. Equine atypical myopathy caused by hypoglycin A intoxication associated with ingestion of sycamore maple tree seeds.. Equine Vet. J. 2016;48:418–442.
- Votion D.M., Habyarimana J.A., Scippo M.L., Richard E.A., Marcillaud-Pitel C., Erpicum M., Gustin P.. Potential new sources of hypoglycin A poisoning for equids kept at pasture in spring: A field pilot study.. Vet. Rec. 2019;184:740.
- Katul G.G., Porporato A., Nathan R., Siqueira M., Soons M.B., Poggi D., Horn H.S., Levin S.A.. Mechanistic analytical models for long-distance seed dispersal by wind.. Am. Nat. 2005;166:368–381.
- Votion D.. Atypical myopathy: An update.. Practice 2016;38:241–246.
- Gonzalez-Medina S., Montesso F., Chang Y.-M., Hyde C., Piercy R.J.. Atypical myopathy-associated hypoglycin A toxin remains in Sycamore seedlings despite mowing, herbicidal spraying or storage in hay and silage.. Equine Vet. J. 2019;51:701–704.
- Renaud B., Francois A.C., Marcillaud-Pitel C., Gustin P., Votion D.. Myopathie atypique: Les différentes sources d’intoxication. Comment gérer le risque?. Journées Sciences et Innovations Équines Institut français du cheval et de l’équitation (Ifce); Saumur, France: 2019. p. 9.
- Cooper J.J., Mason G.J.. The identification of abnormal behaviour and behavioural problems in stabled horses and their relationship to horse welfare: A comparative review.. Equine Vet. J. Suppl. 1998;30:5–9.
- Cooper J.J., Albentosa M.J.. Behavioural adaptation in the domestic horse: Potential role of apparently abnormal responses including stereotypic behavior.. Livest. Prod. Sci. 2005;92:177–182.
- Hosie B.D., Gould P.W., Hunter A.R., Low J.C., Munro R., Wilson H.C.. Acute myopathy in horses at grass in east and south east Scotland.. Vet. Rec. 1986;119:444–449.
- Harris P., Whitwell K.. Atypical myoglobinuria alert.. Vet. Rec. 1990;15:603.
- Westermann C.M., Dorland L., Votion D.M., De Sain-van der Velden M.G.M., Wijnberg I.D., Wanders R.J.A., Spliet W.G.M., Testerink N., Berger R., Ruiter J.P.N.. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy.. Neuromuscul. Disord. 2008;18:355–364.
- Rooney D.K.. Applied nutrition.. Equine Internal Medicine W.B. Saunders; Philadelphia, PA, USA: 2004. pp. 235–272.
- Gonzalez-Medina S., Hyde C., Lovera I., Piercy R.J.. Detection of equine atypical myopathy-associated hypoglycin A in plant material: Optimisation and validation of a novel LC-MS based method without derivatisation.. PLoS ONE 2018;13:13–15.
Citations
This article has been cited 9 times.- François AC, Taminiau B, Renaud B, Gonza-Quito IE, Massey C, Hyde C, Piercy RJ, Douny C, Scippo ML, Daube G, Gustin P, Delcenserie V, Votion DM. In Vitro Investigation of Equine Gut Microbiota Alterations During Hypoglycin A Exposure. Animals (Basel) 2025 Nov 19;15(22).
- François AC, Cesarini C, Taminiau B, Renaud B, Kruse CJ, Boemer F, van Loon G, Palmers K, Daube G, Wouters CP, Lecoq L, Gustin P, Votion DM. Unravelling Faecal Microbiota Variations in Equine Atypical Myopathy: Correlation with Blood Markers and Contribution of Microbiome. Animals (Basel) 2025 Jan 26;15(3).
- Kruse CJ, Dieu M, Renaud B, François AC, Stern D, Demazy C, Burteau S, Boemer F, Art T, Renard P, Votion DM. New Pathophysiological Insights from Serum Proteome Profiling in Equine Atypical Myopathy. ACS Omega 2024 Feb 13;9(6):6505-6526.
- Sander J, Terhardt M, Janzen N, Renaud B, Kruse CJ, François AC, Wouters CP, Boemer F, Votion DM. Tissue Specific Distribution and Activation of Sapindaceae Toxins in Horses Suffering from Atypical Myopathy. Animals (Basel) 2023 Jul 26;13(15).
- Renaud B, Kruse CJ, François AC, Grund L, Bunert C, Brisson L, Boemer F, Gault G, Ghislain B, Petitjean T, Gustin P, Votion DM. Acer pseudoplatanus: A Potential Risk of Poisoning for Several Herbivore Species. Toxins (Basel) 2022 Jul 26;14(8).
- Sander J, Terhardt M, Janzen N. Severe Inhibition of Long-Chain Acyl-CoA Enoylhydratase (EC 4.2.1.74) in a Newborn Foal Suffering From Atypical Myopathy. Front Vet Sci 2021;8:765623.
- Kruse CJ, Stern D, Mouithys-Mickalad A, Niesten A, Art T, Lemieux H, Votion DM. In Vitro Assays for the Assessment of Impaired Mitochondrial Bioenergetics in Equine Atypical Myopathy. Life (Basel) 2021 Jul 20;11(7).
- Bochnia M, Ziegler J, Glatter M, Zeyner A. Hypoglycin A in Cow's Milk-A Pilot Study. Toxins (Basel) 2021 May 26;13(6).
- Wimmer-Scherr C, Taminiau B, Renaud B, van Loon G, Palmers K, Votion D, Amory H, Daube G, Cesarini C. Comparison of Fecal Microbiota of Horses Suffering from Atypical Myopathy and Healthy Co-Grazers. Animals (Basel) 2021 Feb 15;11(2).